Studies have shown that NLRP3 knockout in nonalcoholic steatohepatitis (NASH) mice model inhibited the activation of NLRP3, ASC, and caspase-1 in liver and can significantly reduce liver inflammation in mice and prevent the development of the NASH disease [40, 41]. This evidence concerns the gene CASP1 and inflammation.